|
NASDAQ Top Percentage Gainers; (FSGI), (DLTR), (MAKO), (OPTR)
Category: Investment
Ideas get bigger when you share them...
Visit: Dollar Tree Inc.
New York, New York - February 27, 2013 (www.investorideas.com newswire) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector research for independent investors reports on the top percentage gainers on the NASDAQ for February 27th, 2013.
First Security Group Inc., (NASDAQ:FSGI) trading at $2.26 gained $0.29 or 14.49% on a volume of 10,539 shares, making it today's top percentage gainer on the NASDAQ.
Dollar Tree Inc., (NASDAQ:DLTR) trading at $46.26 rose by $5.18 or 12.60% on a high volume of 6,302,173 shares,
Dollar Tree Inc reported that same-store sales were up every month in Q4, with the strongest sales being in December. The company also estimates that 2013 will see capital expenditures hitting $320 million-$330 million versus $312.2 million in 2012.
MAKO Surgical Corp., (NASDAQ:MAKO) trading at $12.34 moved up $1.34 or 12.18% on a volume of 2,524,800 shares.
MAKO Surgical reported company earnings yesterday for the quarter ended Dec. 31 in which MAKO Surgical missed estimates on revenues as well as earnings per share.
Compared to the prior-year quarter, revenue contracted and the GAAP loss per share dropped.
MAKO Surgical reported revenue of $30.2 million which was below what the seven analysts polled by S&P Capital IQ foresaw with a top line of $31.4 million. GAAP reported sales were 8.1% lower than the prior-year quarter's $32.9 million.
Optimer Pharmaceuticals Inc., (NASDAQ:OPTR) trading at $12.02 gained $1.30 or 12.08% on a volume of 2,364,762 shares.
Optimer Pharmaceuticals Inc announced it is currently exploring a possible sale of the company among a full range of alternatives as well as having replaced its chief executive as part of a review of compliance issues.
The company, which makes diarrhea drug Dificid, said Chairman Henry McKinnell would act as chief executive during its strategic review. He will replace Pedro Lichtinger, CEO since 2010.
Optimer's independent directors recommended management changes following compliance and conflict-of-interest issues observed during a review.
The company also replaced Chief Compliance Officer Kurt Hartman with Meredith Schaum. Optimer sacked co-founder Michael Chang as chairman last April after subsidiary Optimer Biotechnology Inc. (OBI) granted him 1.5 million shares. The company had also removed its finance chief and a vice president for not acting despite having knowledge of the share transfer.
About NASDAQ
http://www.nasdaq.com/
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more .
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and access our 14 online stock directories 24/7 - water, renewable energy, mining stocks and more…
http://www.investorideas.com/membership/
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com
|
